Cargando…

Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine

SIMPLE SUMMARY: RNA-based drugs are an attractive approach for personalized treatment of cancer and other diseases. This review focuses on two related classes of short non-coding RNA: microRNAs (miRNAs) and small interfering RNAs (siRNAs). miRNAs are endogenous short RNAs that bind multiple messenge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Ellen S., Whitty, Eric, Yoo, Byunghee, Moore, Anna, Sempere, Lorenzo F., Medarova, Zdravka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946086/ https://www.ncbi.nlm.nih.gov/pubmed/35326738 http://dx.doi.org/10.3390/cancers14061588

Ejemplares similares

Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
por: Medarova, Zdravka, et al.
Publicado: (2020)

MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2021)

Guidelines for Rational Cancer Therapeutics
por: Yoo, Byunghee, et al.
Publicado: (2017)

New Directions in the Study and Treatment of Metastatic Cancer
por: Yoo, Byunghee, et al.
Publicado: (2018)

Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials
por: Savan, N. Anna, et al.
Publicado: (2022)

MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2019)

Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2017)

Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin
por: Yoo, Byunghee, et al.
Publicado: (2018)

RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
por: Yoo, Byunghee, et al.
Publicado: (2019)

Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
por: Le Fur, Mariane, et al.
Publicado: (2021)

Molecular Imaging: A Promising Tool to Monitor Islet Transplantation
por: Wang, Ping, et al.
Publicado: (2011)

Role of microRNAs in glioblastoma
por: Chen, Ming, et al.
Publicado: (2021)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

microRNA‐based diagnostic and therapeutic applications in cancer medicine
por: Sempere, Lorenzo F., et al.
Publicado: (2021)

Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation
por: Wang, Ping, et al.
Publicado: (2011)

A Theranostic Small Interfering RNA Nanoprobe Protects Pancreatic Islet Grafts From Adoptively Transferred Immune Rejection
por: Wang, Ping, et al.
Publicado: (2012)

Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
por: Chen, Ming, et al.
Publicado: (2023)

Oropharyngeal cancer: the dawn of the RNA era in precision medicine
por: Rampias, Theodoros
Publicado: (2020)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Computational Genomics in the Era of Precision Medicine: Applications to Variant Analysis and Gene Therapy
por: Wang, Yung-Chun, et al.
Publicado: (2022)

INOSA Guidelines in the era of precision medicine
por: Chakraborty, Ranajit
Publicado: (2015)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Cancer Evolution in Precision Medicine Era
por: Karagiannis, Dimitris, et al.
Publicado: (2022)

Antibiotic stewardship in the era of precision medicine
por: Watkins, Richard R
Publicado: (2022)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021)

Multimodality Imaging for Atrial Fibrosis Detection in the Era of Precision Medicine
por: Barletta, Valentina, et al.
Publicado: (2021)

Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine
por: Moore, Donald C., et al.
Publicado: (2023)

Repurposing drugs to treat cardiovascular disease in the era of precision medicine
por: Abdelsayed, Mena, et al.
Publicado: (2022)

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine
por: Suh, Yoon Seok, et al.
Publicado: (2017)

Combining targeted therapeutics in the era of precision medicine
por: Papadatos-Pastos, D, et al.
Publicado: (2015)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Arriving at the Right Diagnosis in an Era of Precision Medicine
por: Pulido, Vina, et al.
Publicado: (2016)

Management of intracranial melanomas in the era of precision medicine
por: Young, Grace J., et al.
Publicado: (2017)

The coming era of precision medicine for intensive care
por: Vincent, Jean-Louis
Publicado: (2017)

Nodular Thyroid Disease in the Era of Precision Medicine
por: Tumino, Dario, et al.
Publicado: (2020)

The Era of Precision Medicine: Reshaping Usher Syndrome
por: Jung, Jinsei
Publicado: (2020)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Personalized Nursing Care in Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jujbe38vuqpp5v27len57l6v46